國立虎尾科技大學 |

Stroke Revisited: Dyslipidemia in Stroke

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Stroke Revisited: Dyslipidemia in Stroke/ edited by Seung-Hoon Lee, Min Kyoung Kang.
其他作者:	Kang, Min Kyoung.
面頁冊數:	XIII, 219 p. 44 illus., 38 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Neurology. -
電子資源:	https://doi.org/10.1007/978-981-16-3923-4
ISBN:	9789811639234

Stroke Revisited: Dyslipidemia in Stroke
Stroke Revisited: Dyslipidemia in Stroke[electronic resource] /edited by Seung-Hoon Lee, Min Kyoung Kang. - 1st ed. 2021. - XIII, 219 p. 44 illus., 38 illus. in color.online resource. - Stroke Revisited,2522-5596. - Stroke Revisited,.

Part 1 Basic Science: Dyslipidemia and Stroke -- 1 Role of Dyslipidemia in Atherosclerosis -- 2 Effects of Dyslipidemia on the Cerebral vessels -- Part 2 Clinical Significance of Dyslipidemia in Stroke -- 3 Impact of Dyslipidemia on Ischemic Stroke -- 4 Dyslipidemia and Hemorrhagic Stroke -- 5 Clinical biomarkers of Dyslipidemia. Part 3 Treatment of Dyslipidemia in Stroke Patients -- 6 Therapeutic Lifestyle Modification -- 7 Statins -- 8 Ezetimibe -- 9 Fibrate and Niacin -- 10 Fish Oils -- 11 PCSK9 inhibiting monoclonal antibodies -- 12 PCSK9 inhibiting siRNA -- 13 Understanding of Clinical Practice Guidelines for Dyslipidemia -- Part 4 Management of Dyslipidemia in Clinical Practice of Stroke -- 14 Practical Management of Dyslipidemia in Stroke Patients -- 15 Practical Dyslipidemia Management in Stroke-specific Situations -- 16 Dyslipidemia in Women: Etiology and Management -- 17 Safety Considerations of Pharmacological Treatment.

This book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerations and pitfalls are also discussed. The individual components of pathophysiology, treatment, and key issues are addressed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. This book is timely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge.

ISBN: 9789811639234

Standard No.: 10.1007/978-981-16-3923-4doiSubjects--Topical Terms:

593894
Neurology.

LC Class. No.: RC346-429.2

Dewey Class. No.: 616.8

Stroke Revisited: Dyslipidemia in Stroke
LDR:03288nam a22004095i 4500 001 1048183
003 DE-He213
005 20210828121519.0
007 cr nn 008mamaa
008 220103s2021 si | s |||| 0|eng d
020 $a 9789811639234 $9 978-981-16-3923-4
024 7 $a 10.1007/978-981-16-3923-4 $2 doi
035 $a 978-981-16-3923-4
050 4 $a RC346-429.2
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKJ $2 thema
082 0 4 $a 616.8 $2 23
245 1 0 $a Stroke Revisited: Dyslipidemia in Stroke $h [electronic resource] / $c edited by Seung-Hoon Lee, Min Kyoung Kang.
250 $a 1st ed. 2021.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a XIII, 219 p. 44 illus., 38 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Stroke Revisited, $x 2522-5596
505 0 $a Part 1 Basic Science: Dyslipidemia and Stroke -- 1 Role of Dyslipidemia in Atherosclerosis -- 2 Effects of Dyslipidemia on the Cerebral vessels -- Part 2 Clinical Significance of Dyslipidemia in Stroke -- 3 Impact of Dyslipidemia on Ischemic Stroke -- 4 Dyslipidemia and Hemorrhagic Stroke -- 5 Clinical biomarkers of Dyslipidemia. Part 3 Treatment of Dyslipidemia in Stroke Patients -- 6 Therapeutic Lifestyle Modification -- 7 Statins -- 8 Ezetimibe -- 9 Fibrate and Niacin -- 10 Fish Oils -- 11 PCSK9 inhibiting monoclonal antibodies -- 12 PCSK9 inhibiting siRNA -- 13 Understanding of Clinical Practice Guidelines for Dyslipidemia -- Part 4 Management of Dyslipidemia in Clinical Practice of Stroke -- 14 Practical Management of Dyslipidemia in Stroke Patients -- 15 Practical Dyslipidemia Management in Stroke-specific Situations -- 16 Dyslipidemia in Women: Etiology and Management -- 17 Safety Considerations of Pharmacological Treatment.
520 $a This book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerations and pitfalls are also discussed. The individual components of pathophysiology, treatment, and key issues are addressed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. This book is timely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge.
650 1 4 $a Neurology. $3 593894
650 0 $a Neurology . $3 1253459
700 1 $a Kang, Min Kyoung. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1351991
700 1 $a Lee, Seung-Hoon. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1200403
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811639227
776 0 8 $i Printed edition: $z 9789811639241
776 0 8 $i Printed edition: $z 9789811639258
830 0 $a Stroke Revisited, $x 2522-5588 $3 1281241
856 4 0 $u https://doi.org/10.1007/978-981-16-3923-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)